Zevra Therapeutics, Inc.

ZVRA·NASDAQ·$10.32Share Price as of 11/2·$610MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202503/09/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report08/05/26 8-KCurrent report06/05/26 8-KCurrent report05/06/26 8-KCurrent report03/16/26 8-KCurrent report03/09/26

Prospectuses and Registrations

S-8Registration of securities for employees03/09/26 S-8Registration of securities for employees03/13/25 424B5Prospectus supplement08/09/24 424B5Prospectus supplement08/08/24 424B2Prospectus for primary offering07/12/24

Proxies

DEF 14ADefinitive proxy04/20/26 PRE 14APreliminary proxy04/06/26 DEFA14AAdditional proxy materials05/21/25 DEFA14AAdditional proxy materials05/08/25 DEFC14ADefinitive proxy (contested)04/29/25

Ownership

144Proposed sale of securities10/13/26 Form 4Insider transaction10/13/26 Form 4Insider transaction08/17/26 144Proposed sale of securities08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26

Other

UPLOADLetter from the SEC04/17/25 UPLOADLetter from the SEC04/11/25 EFFECTRequest for effectiveness06/13/24 CORRESPCorrespondence with the SEC06/10/24 UPLOADLetter from the SEC06/07/24